Interleukin-1 directly regulates hormone-dependent human breast cancer cell proliferation in vitro

Mol Endocrinol. 1988 May;2(5):459-64. doi: 10.1210/mend-2-5-459.

Abstract

Direct in vitro effects of IL-1 on hormone-dependent (MCF-7 and ZR-75-B) and independent (HS-578-T and MDA-231) human breast cancer cell proliferation were investigated in short-term and long-term cell cultures. For short-term (48 h) studies [3H]thymidine uptake was used as an index of proliferation, while for long-term (12 day) cultures actual cell numbers were determined. Initial studies, conducted with MCF-7 cells, demonstrated that both forms of recombinant human IL-1 (alpha and beta) at 10(-11) M inhibited [3H]thymidine uptake by MCF-7 by 70%, and by day 7 of the long-term study alpha and beta IL-1 at 10(-11) M inhibited MCF-7 cell growth by 80%. IL-1, while inhibiting the growth of another hormone-dependent breast cancer cell line; ZR-75-B, had no effect on the hormone-independent cell lines MDA-231 and HS-578-T. The differing proliferative responses of the hormone-dependent and independent cells to IL-1 may, in part, be due to the expression of IL-1 receptors on these cells, in that MCF-7 cells express IL-1 receptors [dissociation constant (Kd) = 2.0 x 10(-10) M; receptor density = 2,500 sites per cell and mol wt = 80,000] while the hormone-independent MDA-231 cells do not.

MeSH terms

  • Binding, Competitive
  • Breast Neoplasms / drug therapy*
  • Cell Division / drug effects
  • Female
  • Humans
  • Interleukin-1 / pharmacology*
  • Isotope Labeling
  • Neoplasms, Hormone-Dependent / drug therapy*
  • Receptors, Immunologic / physiology
  • Receptors, Interleukin-1
  • Thymidine / metabolism
  • Tritium / metabolism
  • Tumor Cells, Cultured

Substances

  • Interleukin-1
  • Receptors, Immunologic
  • Receptors, Interleukin-1
  • Tritium
  • Thymidine